期刊文献+

核苷(酸)类似物停药后HBeAg阴性慢性乙型肝炎复发的临床研究

Relapse of patients with HBeAg negative chronic hepatitis B after nucleos(t) ide analogues drug withdrawal
原文传递
导出
摘要 目的观察HBe Ag阴性慢性乙型肝炎患者核苷(酸)类似物(NUCs)停药后病情复发情况,分析相关因素。方法选择2011年6月—2015年6月在太仓市第一人民医院和苏州市第五人民医院住院及门诊服用NUCs停药后复发的HBe Ag阴性慢性乙型肝炎患者39例,分为规范停药后复发组(A组)16例和不规范停药后复发组(B组)23例。另外选择同期服用NUCs停药后1年内未复发的HBe Ag阴性慢性乙型肝炎患者9例作为未复发组。分析停药后1年内肝炎复发情况和相关因素。结果未复发组患者基线血清HBV DNA低于A、B组,差异有统计学意义(P<0.05),A组基线血清HBV DNA与B组比较,差异无统计学意义(P>0.05);未复发组患者基线血清HBs Ag水平低于B组,差异有统计学意义(P<0.05),但与A组比较,差异无统计学意义(P>0.05);未复发组患者停药时血清HBs Ag水平低于A、B组,差异有统计学意义(P<0.05),A组停药时血清HBs Ag水平与B组比较,差异无统计学意义(P>0.05)。结论 HBe Ag阴性慢性乙型肝炎患者服用NUCs规范停药或不规范停药后1年内均有复发,不规范停药后6个月以内复发率较高,患者基线血清HBV DNA水平、基线血清HBs Ag或停药时血清HBs Ag水平与复发可能有关。 Objective To analyze the relapse and related factors of the HBe Ag negative chronic hepatitis B after nucleos( t) ide analogues( NUCs) drug withdrawal. Methods A total of 39 patients with HBe Ag negative chronic hepatitis B after NUCs drug withdrawal in the First People’ s Hospital of Taicang City and the Fifth People’ s Hospital of Suzhou City from June 2011 to June 2015 were selected,they were divided into A group( with relapse after standard drug discontinuance,n =16) and B group( with relapse after non standard drug discontinuance,n = 23). A total of 9 patients with HBe Ag negative chronic hepatitis B treated by NUCs( without relapse within 1 year of drug discontinuance) were selected as C group at the same time. The incidence of relapse and related factors were analyzed. Results Baseline serum HBV DNA of C group was lower than A,B group( P < 0. 05),baseline serum HBV DNA between A group and B group showed no significant differences( P >0. 05); baseline serum HBs Ag of C group was lower than B group( P < 0. 05),but compared with A group,the differences were not statistically significant( P > 0. 05); serum HBs Ag of C group was lower than the A,B group( P < 0. 05),serum HBs Ag between A group and B group showed no significant differences( P > 0. 05). Conclusion HBe Ag negative chronic hepatitis B patients taking NUCs with standard drug discontinuance or not appear relapse within 1 year,patients with non- standard drug has high recurrence rate within the six months baseline serum HBV DNA,baseline serum HBs Ag or discontinuation of serum HBs Ag levels maybe associated with recurrence.
出处 《临床合理用药杂志》 2016年第9期10-12,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 乙型肝炎 慢性 乙型肝炎E抗原 核苷(酸)类似物 复发 Hepatitis B,chronic Hepatitis B e antigens Nucleos(t) ide analogues Recurrence
  • 相关文献

参考文献5

  • 1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 2Henry Lik–Yuen Chan,Vincent Wai–Sun Wong,Ada Mei–Ling Tse,Chi–Hang Tse,Angel Mei–Ling Chim,Hoi–Yun Chan,Grace Lai–Hung Wong,Joseph Jao–Yiu Sung.Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response[J].Clinical Gastroenterology and Hepatology.2007(12)
  • 3Danny Ka-Ho Wong,Wai-Kay Seto,James Fung,Philip Ip,Fung-Yu Huang,Ching-Lung Lai,Man-Fung Yuen.??Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency(J)Clinical Gastroenterology and Hepatology . 2013 (8)
  • 4Joseph J.Y. Sung,May-Ling Wong,Scott Bowden,Choong-Tsek Liew,Alex Y. Hui,Vincent W.S. Wong,Nancy W.Y. Leung,Stephen Locarnini,Henry L.Y. Chan.Intrahepatic Hepatitis B Virus Covalently Closed Circular DNA Can Be a Predictor of Sustained Response to Therapy[J]. Gastroenterology . 2005 (7)
  • 5Wen‐Juei Jeng,I‐Shyan Sheen,Yi‐Cheng Chen,Chao‐Wei Hsu,Rong‐Nan Chien,Chia‐Ming Chu,Yun‐Fan Liaw.??Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients(J)Hepatology . 2013 (6)

二级参考文献10

共引文献835

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部